1h-tetrazole has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhosale, VM; Chakraborti, S; Deshmukh, S; Gharat, LA; Gudi, GS; Jadhav, SB; Khairatkar-Joshi, N; Kulkarni, A; Mahat, MYA; Mhatre, S; Muthukaman, N; Pisal, D; Sarode, N; Shah, D; Tambe, M; Tondlekar, S | 1 |
1 other study(ies) available for 1h-tetrazole and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD.
Topics: Administration, Oral; Aldehyde Oxidoreductases; Animals; Cigarette Smoking; Enzyme Inhibitors; Halogenation; Humans; Imidazoles; Male; Mice; Mice, Inbred C57BL; Pulmonary Disease, Chronic Obstructive; Structure-Activity Relationship; Tetrazoles | 2018 |